Literature DB >> 17068466

Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases.

Keith Walter1, Marshall E Tyler.   

Abstract

PURPOSE: To describe 2 cases of sterile corneal ulcers that persisted after several weeks of therapy with topical moxifloxacin 0.5% but that resolved when antibiotic therapy was changed.
METHODS: Small case series.
RESULTS: Both cases presented here describe corneal ulcers that persisted and showed signs of worsening during weeks of frequent topical dosing with moxifloxacin. Descemet folds and an atypically large amount of stromal edema were present in both cases, and there appeared to be possible endothelial dysfunction as well. There was no sign of bacterial, viral, or fungal infection in either case. In both cases, healing began a few days after moxifloxacin was discontinued, and topical gatifloxacin and corticosteroids were initiated.
CONCLUSION: These cases suggest that moxifloxacin may interfere with the healing of corneal ulcers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068466     DOI: 10.1097/01.ico.0000224642.43601.14

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  5 in total

1.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05

2.  Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains.

Authors:  Saichi Hoshi; Ken Kikuchi; Takashi Sasaki; Chie Sotozono; Shigeru Kinoshita; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

3.  Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines.

Authors:  Masahiko Ayaki; Atsuo Iwasawa; Mitsutaka Soda; Shigeo Yaguchi; Ryohei Koide
Journal:  Clin Ophthalmol       Date:  2010-09-20

4.  Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.

Authors:  Darlene Miller
Journal:  Clin Ophthalmol       Date:  2008-03

5.  A Case Report of Severe Corneal Toxicity following 0.5% Topical Moxifloxacin Use.

Authors:  A P Vignesh; Renuka Srinivasan; Swathi Karanth
Journal:  Case Rep Ophthalmol       Date:  2015-02-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.